My-HyperCVAD in the Treatment of Relapsed Refractory Adult Acute Lymphoid Leukemia

Update Il y a 4 ans
Reference: NCT00801580

Woman and Man

  • | Country :
  • Italy
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The patient receive 2 different drug combinations on this study. The first combination will consist of an intensive chemotherapy regimen (cyclophosphamide, mesna, methotrexate, doxorubicin liposomal or doxorubicin, vincristine, ARA-C (cytarabine) and dexamethasone). The second combination will consist of another intensive chemotherapy regimen (methotrexate and Ara-C [cytarabine]).


Inclusion criteria

  • Lymphoid leukemia

Links